Literature DB >> 33836428

Pseudomonas aeruginosa, the type of mutation, lung function, and nutritional status in adults with cystic fibrosis.

Aleksandra John1, Joanna Goździk-Spychalska2, Magdalena Durda-Masny1, Wojciech Czaiński2, Natalia Pawłowska1, Jolanta Wlizło2, Halina Batura-Gabryel2, Anita Szwed3.   

Abstract

OBJECTIVE: The aim of this study was to describe the relationship between the prevalence of Pseudomonas aeruginosa (PA) and lung function, as well as the nutritional status and type of gene mutation in adult patients with cystic fibrosis (CF).
METHODS: This cross-sectional study evaluated 103 Polish adults with CF the following: • The occurrence of PA and the level of bacterial susceptibility to antibiotics; • Type of mutation in the CFTR gene; • Nutritional status assessed by body mass index (BMI), and • Lung function measured by forced expiratory volume in 1 s (FEV1%).
RESULTS: The absence or presence of PA and the level of bacterial resistance were significantly related to the type of gene mutation (P < 0.001). In patients with a severe mutation, PA more often was extensively drug resistant or pandrug resistant compared with Pseudomonas culture-negative patients or patients with mild or unclassified mutations on both alleles. Associations were found between the presence of PA and lower values of BMI (P < 0.001), and FEV1% (P < 0.001). The risk for PA occurrence and the development of bacterial resistance increased twice in the case of severe mutation (odds ratio [OR], 2.51; 95% confidence interval [CI], 1.62-3.89), four times when BMI decreased <18.5 (OR, 4.15; 95% CI, 1.43-10.08). and six times when FEV1% fell <40 (OR, 6.75; 95% CI, 3.11-14.64).
CONCLUSIONS: The presence of PA is associated with lower FEV1% and BMI values. Deterioration of lung function, undernutrition, and severe type of gene mutation are linked to a higher probability of PA acquisition and resistance to antibiotic treatment.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMI; Cystic fibrosis; FEV1%; Pseudomonas aeruginosa

Year:  2021        PMID: 33836428     DOI: 10.1016/j.nut.2021.111221

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  4 in total

1.  Potential Association Between Changes in Microbiota Level and Lung Diseases: A Meta-Analysis.

Authors:  Lan Chai; Qi Wang; Caijuan Si; Wenyan Gao; Lun Zhang
Journal:  Front Med (Lausanne)       Date:  2022-01-14

2.  The determinants of survival among adults with cystic fibrosis-a cohort study.

Authors:  Magdalena Durda-Masny; Joanna Goździk-Spychalska; Aleksandra John; Wojciech Czaiński; Weronika Stróżewska; Natalia Pawłowska; Jolanta Wlizło; Halina Batura-Gabryel; Anita Szwed
Journal:  J Physiol Anthropol       Date:  2021-11-08       Impact factor: 2.867

3.  Isolation and characterization of two homolog phages infecting Pseudomonas aeruginosa.

Authors:  Niu Yuanyuan; Yang Xiaobo; Wang Shang; Yang Yutong; Zhou Hongrui; Li Chenyu; Xue Bin; Zhang Xi; Zhao Chen; Shen Zhiqiang; Wang Jingfeng; Ling Yun; Yu Pingfeng; Qiu Zhigang
Journal:  Front Microbiol       Date:  2022-07-14       Impact factor: 6.064

4.  Case Report: Japanese Siblings of Cystic Fibrosis With a Novel Large Heterozygous Deletion in the CFTR Gene.

Authors:  Mayumi Kawase; Masato Ogawa; Takayuki Hoshina; Masumi Kojiro; Miyuki Nakakuki; Satoru Naruse; Hiroshi Ishiguro; Koichi Kusuhara
Journal:  Front Pediatr       Date:  2022-01-03       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.